193 related articles for article (PubMed ID: 15315007)
1. Plasma activity of interleukin-10 in drug-induced cutaneous reactions.
Chodorowska G; Czelej D; Krasowska D; Pietrzak A
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):317-21. PubMed ID: 15315007
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 and its soluble receptor in selected drug-induced cutaneous reactions.
Chodorowska G; Czelej D; Niewiedzioł M
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):7-13. PubMed ID: 15323158
[TBL] [Abstract][Full Text] [Related]
3. Activity of Tumor Necrosis Factor-alpha (TNF-alpha) and its soluble type I receptor (p55TNF-R) in some drug-induced cutaneous reactions.
Chodorowska G; Czelej D; Niewiedzioł M
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):50-6. PubMed ID: 15323166
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma.
Chodorowska G; Czelej D
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):43-7. PubMed ID: 15314957
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma.
Czelej D; Chodorowska G; Lechowska-Mazur I
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):38-42. PubMed ID: 15314956
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
[TBL] [Abstract][Full Text] [Related]
8. Plasma activity of interleukin-6 and some acute phase proteins in severe drug-induced skin adverse reactions.
Czelej D; Chodorowska G; Lecewicz-Toruń B
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):62-7. PubMed ID: 12898820
[TBL] [Abstract][Full Text] [Related]
9. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 and some acute phase proteins plasma activity in drug-induced maculopapular eruptions.
Chodorowska G; Czelej D; Roguś-Skorupska D
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):180-4. PubMed ID: 16145976
[TBL] [Abstract][Full Text] [Related]
11. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
[TBL] [Abstract][Full Text] [Related]
12. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
13. T cell populations propagating in the peripheral blood of patients with drug eruptions.
Nishio D; Izu K; Kabashima K; Tokura Y
J Dermatol Sci; 2007 Oct; 48(1):25-33. PubMed ID: 17601705
[TBL] [Abstract][Full Text] [Related]
14. Expression of α-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions.
Morel E; Alvarez L; Cabañas R; Fiandor A; Díaz R; Escamochero S; Prior N; Blanca M; Bellón T
Allergy; 2011 Mar; 66(3):360-7. PubMed ID: 20880148
[TBL] [Abstract][Full Text] [Related]
15. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes.
Assier H; Bastuji-Garin S; Revuz J; Roujeau JC
Arch Dermatol; 1995 May; 131(5):539-43. PubMed ID: 7741539
[TBL] [Abstract][Full Text] [Related]
16. Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment.
Murata J; Abe R; Shimizu H
J Allergy Clin Immunol; 2008 Nov; 122(5):992-1000. PubMed ID: 18692887
[TBL] [Abstract][Full Text] [Related]
17. Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hung CC; Liu WC; Kuo MC; Lee CH; Hwang SJ; Chen HC
Am J Nephrol; 2009; 29(6):633-8. PubMed ID: 19155617
[TBL] [Abstract][Full Text] [Related]
18. [Skin and hair].
Briner VA
Schweiz Med Wochenschr; 1996 Apr; 126(14):549-58. PubMed ID: 8668968
[TBL] [Abstract][Full Text] [Related]
19. Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity.
Morsy H; Taha EA; Nigm DA; Shahin R; Youssef EMK
Clin Exp Dermatol; 2017 Dec; 42(8):868-873. PubMed ID: 28940568
[TBL] [Abstract][Full Text] [Related]
20. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
